Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Lanifibranor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 247,643Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inventiva To Showcase Multiple Abstracts At AASLD Liver Meeting
    Inventiva To Showcase Multiple Abstracts At AASLD Liver Meeting

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162920/0/en/Inventiva-to-Present-Multiple-Abstracts-at-AASLD-The-Liver-Meeting-2025.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share
    Inventiva Receives $10 Million Milestone Payment from CTTQ
    Inventiva Receives $10 Million Milestone Payment from CTTQ

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3111282/0/en/Inventiva-receives-10-million-milestone-payment-from-CTTQ.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share
    Inventiva publishes new biomarker analysis in MASH Patients
    Inventiva publishes new biomarker analysis in MASH Patients

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067894/0/en/Inventiva-announces-the-publication-in-Clinical-Gastroenterology-and-Hepatology-of-its-analysis-of-new-biomarker-signatures-predictive-of-histological-response-in-patients-with-MAS.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    Inventiva completes enrollment in Phase 3 trial of lanifibranor
    Inventiva completes enrollment in Phase 3 trial of lanifibranor

    01 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/01/3053830/0/en/Inventiva-announces-completion-of-enrollment-in-the-Phase-3-NATiV3-clinical-trial-of-lanifibranor-in-patients-with-MASH-and-advanced-fibrosis.html

    GLOBENEWSWIRE
    01 Apr 2025
    Share Share
    Inventiva Preclinical Study Lanifibranor Improves Portal Hypertension
    Inventiva Preclinical Study Lanifibranor Improves Portal Hypertension

    26 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/26/3033295/0/en/Inventiva-announces-the-publication-in-Biomedicine-Pharmacotherapy-of-the-results-from-a-preclinical-study-showing-improvement-of-portal-hypertension-with-lanifibranor-treatment.html

    GLOBENEWSWIRE
    26 Feb 2025
    Share Share
    Inventiva, Hepalys Dose First Participant In Japan Ph 1 Lanifibranor Trial
    Inventiva, Hepalys Dose First Participant In Japan Ph 1 Lanifibranor Trial

    20 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/20/3030046/0/en/Inventiva-and-Hepalys-Pharma-Inc-announce-the-initiation-of-the-clinical-development-program-of-lanifibranor-in-Japan-with-the-dosing-of-the-first-participant-in-Phase-1-trial.html

    GLOBENEWSWIRE
    20 Feb 2025
    Share Share